Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults - Guittet, C.; Roussel-Maupetit, C.; Manso-Silván, M. A.; Guillaumin, F.; Vandenhende, F.; Granier, L. A. (Scientific reports, 2020)
Keywords: 631/154; 692/4022; 692/4025; Administration, Oral; Adult; Antacids - pharmacology; Bicarbonates; Bicarbonates - pharmacology; Citric acid; Delayed-Action Preparations - administration & dosage; Delayed-Action Preparations - chemistry; Delayed-Action Preparations - pharmacology; Dosage; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humanities and Social Sciences; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; multidisciplinary; pH effects; Potassium; Potassium Citrate - pharmacology; Potassium Compounds - pharmacology; Salts; Science; Science (multidisciplinary); Urine; Urine - chemistry